UN Development Agency Issues Guidelines For Pharmaceutical Patent Examiners 15/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment A new set of guidelines for pharmaceutical patent examination has been published by the United Nations Development Programme that seek to help reduce poor quality patents and ensure efficient market entry of generic products. The guidelines, written by a well-known advocate of access to medicines, aim at advising patent examiners in assessing the patentability requirements of applications relating to pharmaceutical products and processes.
More Changes In UN Agencies; Movements In Global Health 14/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment Movement has been happening in international organisations in recent weeks, particularly in United Nations agencies, as new executive directors were nominated, and department directorships changed hands. The private sector and non-governmental organisations also saw a number of position switches and nominations, in particular in the health sector. Law offices kept pace with the usual chair revolving.
Innovation et accès : fission ou fusion ? Entretien avec Tim Wilsdon, Vice-président de CRA 14/06/2016 by William New, Intellectual Property Watch Leave a Comment Dans le sillage du Groupe de Haut Niveau des Nations Unies sur l’accès aux médicaments, cette série d’articles sponsorisés convie des experts à donner leur point de vue sur les politiques les mieux à même de favoriser l’élaboration de solutions aux plus importants enjeux sociétaux ; ils nous expliquent aussi comment un cadre réglementaire favorable, y […]
Alongside UN Commitments To End AIDS, Event On Access Brings Tears, Vision 13/06/2016 by William New, Intellectual Property Watch 1 Comment NEW YORK — Last week, United Nations members agreed on a political declaration on ending AIDS by 2030, with some new and old commitments. Alongside the 8-10 June High-Level Meeting on Ending AIDS, a side event looked at issues of access and got into intellectual property rights issues.
Antibiotic Resistance Is “Already Here” And Pipeline Is Dry, UK Health Minister Tells UN 08/06/2016 by William New, Intellectual Property Watch 2 Comments NEW YORK — An estimated one million people may already die each year because they are resistant to all known antibiotics, and the number could reach 10 million per year and devastate the world economy by 2050 unless key steps are taken, experts from the United Kingdom and South Africa told a press briefing on antimicrobial resistance at United Nations headquarters today.
Innovation And Access: Fission Or Fusion? Interview With Dr. Kristina M. Lybecker, Associate Professor Of Economics At Colorado College 02/06/2016 by Guest contributor for Intellectual Property Watch 1 Comment In the light of the UN High-Level Panel on Access to Medicines, this series of sponsored articles challenges experts to give their views on the policies that best support the development of solutions to societies’ greatest challenges and how enabling policy environments, including IP systems, influence the development and flow of new technologies and services in different sectors, fields of technology, and jurisdictions. The views expressed in the articles are those of the authors. Below is an interview with Dr. Kristina M. Lybecker, Associate Professor of Economics at Colorado College in Colorado Springs (US).
WHA Gets First UN Framework Managing Non-State Actors; Countries Satisfied, Actors Concerned 30/05/2016 by Catherine Saez, Intellectual Property Watch 3 Comments The first agreement on how to manage relationships between a United Nations organisation and non-governmental actors, such as industry, philanthropic organisations and public interest groups, was adopted on 28 May by the World Health Assembly. The framework, which had been discussed for several years, was hailed as historic by many countries, but met a mixed reaction from those primarily concerned.
Innovation et accès : fission ou fusion ? Entretien avec David Taylor, Professeur en Politique Pharmaceutique et de Santé Publique à l’UCL (University College London) 30/05/2016 by Guest contributor for Intellectual Property Watch Leave a Comment Dans le sillage du Groupe de Haut Niveau des Nations Unies sur l’accès aux médicaments (UN High-Level Panel on Access to Medicines) cette série d’articles sponsorisés convie des experts à donner leur point de vue sur les politiques les mieux à même de favoriser l’élaboration de solutions aux plus importants enjeux sociétaux, ainsi que sur la manière dont un cadre réglementaire favorable –y compris les systèmes de protection de la propriété intellectuelle – influence le développement et la diffusion de nouvelles technologies et de nouveaux services au sein de différents secteurs, domaines technologiques et juridictions. Les opinions exprimées dans ces articles n’engagent que leurs auteurs.
Innovación y acceso: ¿fisión o fusión? Entrevista a David Taylor, profesor de Políticas Farmacéuticas y de Salud Pública del University College de Londres 30/05/2016 by Guest contributor for Intellectual Property Watch Leave a Comment Tomando como referencia el trabajo del Grupo de Alto Nivel de las Naciones Unidas sobre el Acceso a los Medicamentos (UN High-Level Panel on Access to Medicines), esta serie de artículos patrocinados invita a expertos en la materia a expresar sus puntos de vista sobre las políticas que respaldan con mayor eficacia la formulación de soluciones que respondan a los principales desafíos de las sociedades, y sobre cómo los entornos propicios para la implantación de políticas, incluidas las relativas a los sistemas de propiedad intelectual, influyen en el desarrollo y el caudal de nuevas tecnologías y servicios en diferentes sectores, campos tecnológicos y territorios. Las opiniones expresadas en los artículos son las del autor.
Global Health In The Glare In G7 Final Resolutions; Trade Deals Promised For 2016 27/05/2016 by Monika Ermert for Intellectual Property Watch Leave a Comment Reform of the WHO, support for the Contingency Fund for Emergency to enable swift initial responses by the WHO, and a special R&D and innovation chapter in the G7 Ise-Shima Vision for Global Health that does not include the word intellectual property are some of the notables after the G7 Summit closed today in Japan. Counting pages, Global Health and lessons from the recent Ebola and Zika outbreaks did receive the biggest attention. But the G7 would not be its old usual without considerable warnings and some concrete proposals how to fight global terrorism and violent extremism.